PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsTyrosinemias
MeSH D020176 - tyrosinemias
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D020739:Metabolic brain diseases inborn
0 Companies
0 Drugs
Success rate
D000592:Inborn errors amino acid metabolism
$
Success rate
D020176: 
Tyrosinemias
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
RocheFolic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Ergocalciferol, Vitamin a, Biotin, Niacinamide, Pyridoxine, Riboflavin, Thiamine Berocca Pn  1985-10-10   
SandozFolic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Vitamin a, Alpha-tocopherol, Biotin, Cholecalciferol, Niacinamide, Pyridoxine, Riboflavin, Thiamine, Tocopherol Infuvite  2000-05-18   
HospiraFolic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Ergocalciferol, Vitamin a, Biotin, Niacinamide, Pyridoxine, Riboflavin, Thiamine, Phytonadione M.v.i.  1985-08-08   
Folic acid, Ascorbic acid, Cyanocobalamin, Ergocalciferol, Phytonadione, Vitamin a, Biotin, Niacinamide, Pantothenic acid, Pyridoxine, Riboflavin, Thiamine Vitaped  1993-12-29   
Cycle PharmaceuticalsNitisinone Nityr  2018-07-26   
Novitium PharmaNitisinone Nitisinone  2019-08-26   
MedunikNitisinone Nitisinone  2022-05-26   
Orphan MedicalNitisinone Orfadin  2002-01-18   
TeligentFolic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Ergocalciferol, Vitamin a, Biotin, Niacinamide, Pyridoxine, Riboflavin, Thiamine M.v.i. Lyophilized  1985-08-08   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
0%
0/0
Phase 3
100%
4/4
Approved: 3Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Roche
Cycle Pharmaceuticals
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use